Almokalant exhibits use-dependent block and unblock of the delayed rectifier K+ current in rabbit ventricular myocytes, consistent with the drug being trapped by the closure of the activation gate.
Answers are grounded in this paper and cite their sources.
Almokalant’s use-dependent IK block in rabbit myocytes warrants further study; leaves open translation to human antiarrhythmic therapy.
A voltage-clamp analysis of the effect of almokalant on the delayed rectifier K+ current (IK) was made in rabbit ventricular myocytes. The two-suction pipette method was used, and appropriate voltage-clamp protocols were used to study more specifically use dependence, block development, and recovery from block. Almokalant interacted with the IK in two ways: it shifted the activation curve in the hyperpolarizing direction (stimulatory effect) and blocked the open IK channel in a use-dependent way (inhibitory effect). For 2-second voltage clamps to +20 mV, half-maximum block was obtained at 5 x 10(-8) mol/L, with a Hill coefficient of 1.76. Use-dependent block was related to an open-channel block that occurred at 0 mV with a time constant of 1.07 second and a rather slow recovery from block: at -50 mV, recovery time constant was approximately 10 seconds; at -75 mV, recovery was practically absent. The absence of an important recovery at negative membrane potentials is consistent with the hypothesis of the drug being trapped in the channel. A limited frequency-dependent block could be demonstrated. Use-dependent unblock was demonstrated by a rapid recovery from block during stimulation following complete washout of the drug. It is concluded that almokalant shifts the activation curve of IK in the hyperpolarizing direction, blocks the open channel, and is trapped by the closure of the activation gate.
No takes yet. Share an insight, caveat, or question.
Edward Carmeliet (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: